Some directors and senior executives of Zhejiang Haisen Pharmaceutical (001367.SZ) plan to reduce their holdings by a total of no more than 124,300 shares.
Haisen Pharmaceutical (001367.SZ) announced that some directors and senior management of the company plan to collectively reduce their holdings of the company's shares by 124,300 shares (0.0816% of the total share capital) through centralized bidding trading within 3 months after 15 trading days from the disclosure of this announcement (from December 26, 2025 to March 25, 2026).
Zhejiang Haisen Pharmaceutical (001367.SZ) announced that some directors and senior management of the company plan to collectively reduce their holdings of the company's shares by a total of 12.43 million shares (0.0816% of the total share capital) through centralized competitive trading within 3 months after 15 trading days from the date of this announcement, from December 26, 2025 to March 25, 2026.
Related Articles
BOYAA (00434) spent approximately HKD 797,500 to repurchase 200,000 shares on December 4th.
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) has to pay approximately 4.2 million yuan in back taxes.
YEE HOP HLDGS (01662) Subsidiary Trio AI partners with ABBY Pay to establish a strategic cooperation relationship, intending to jointly explore, develop, and implement innovative artificial intelligence-driven payment processing solutions.
BOYAA (00434) spent approximately HKD 797,500 to repurchase 200,000 shares on December 4th.
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) has to pay approximately 4.2 million yuan in back taxes.
YEE HOP HLDGS (01662) Subsidiary Trio AI partners with ABBY Pay to establish a strategic cooperation relationship, intending to jointly explore, develop, and implement innovative artificial intelligence-driven payment processing solutions.
